Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Erik Karl Alexander, M.D.

Co-Author

This page shows the publications co-authored by Erik Alexander and Ellen Marqusee.
Connection Strength

4.547
  1. Natural history of benign solid and cystic thyroid nodules. Ann Intern Med. 2003 Feb 18; 138(4):315-8.
    View in: PubMed
    Score: 0.265
  2. Assessment of nondiagnostic ultrasound-guided fine needle aspirations of thyroid nodules. J Clin Endocrinol Metab. 2002 Nov; 87(11):4924-7.
    View in: PubMed
    Score: 0.259
  3. Point of Care Measurement of Body Mass Index and Thyroid Nodule Malignancy Risk Assessment. Front Endocrinol (Lausanne). 2022; 13:824226.
    View in: PubMed
    Score: 0.247
  4. Performance of Thyroid-Stimulating Immunoglobulin Bioassay and Thyrotropin-Binding Inhibitory Immunoglobulin Assay for the Diagnosis of Graves' Disease in Patients With Active Thyrotoxicosis. Endocr Pract. 2022 Jan 25.
    View in: PubMed
    Score: 0.246
  5. A Cohort Analysis of Clinical and Ultrasound Variables Predicting Cancer Risk in 20,001 Consecutive Thyroid Nodules. J Clin Endocrinol Metab. 2019 11 01; 104(11):5665-5672.
    View in: PubMed
    Score: 0.211
  6. Discordance of serological and sonographic markers for Hashimoto's thyroiditis with gold standard histopathology. Eur J Endocrinol. 2019 Nov; 181(5):539-544.
    View in: PubMed
    Score: 0.211
  7. The Impact of Hashimoto Thyroiditis on Thyroid Nodule Cytology and Risk of Thyroid Cancer. J Endocr Soc. 2019 Apr 01; 3(4):791-800.
    View in: PubMed
    Score: 0.201
  8. POSITIVE THYROTROPIN RECEPTOR ANTIBODIES IN PATIENTS WITH TRANSIENT THYROTOXICOSIS. Endocr Pract. 2018 Jun; 24(6):512-516.
    View in: PubMed
    Score: 0.189
  9. Differential Growth Rates of Benign vs. Malignant Thyroid Nodules. J Clin Endocrinol Metab. 2017 12 01; 102(12):4642-4647.
    View in: PubMed
    Score: 0.184
  10. Clinical, Sonographic, and Pathological Characteristics of RAS-Positive Versus BRAF-Positive Thyroid Carcinoma. J Clin Endocrinol Metab. 2016 12; 101(12):4938-4944.
    View in: PubMed
    Score: 0.170
  11. Long- versus short-interval follow-up of cytologically benign thyroid nodules: a prospective cohort study. BMC Med. 2016 Jan 27; 14:11.
    View in: PubMed
    Score: 0.162
  12. Bethesda Categorization of Thyroid Nodule Cytology and Prediction of Thyroid Cancer Type and Prognosis. Thyroid. 2016 Feb; 26(2):256-61.
    View in: PubMed
    Score: 0.161
  13. The Influence of Patient Age on Thyroid Nodule Formation, Multinodularity, and Thyroid Cancer Risk. J Clin Endocrinol Metab. 2015 Dec; 100(12):4434-40.
    View in: PubMed
    Score: 0.159
  14. The variable phenotype and low-risk nature of RAS-positive thyroid nodules. BMC Med. 2015 Aug 07; 13:184.
    View in: PubMed
    Score: 0.157
  15. Long-term, treatment-free survival in select patients with distant metastatic papillary thyroid cancer. Endocr Connect. 2014 Dec; 3(4):207-14.
    View in: PubMed
    Score: 0.148
  16. Determination of the optimal time interval for repeat evaluation after a benign thyroid nodule aspiration. J Clin Endocrinol Metab. 2014 Feb; 99(2):510-6.
    View in: PubMed
    Score: 0.140
  17. Subacute granulomatous (de Quervain) thyroiditis: grayscale and color Doppler sonographic characteristics. J Ultrasound Med. 2013 Mar; 32(3):505-11.
    View in: PubMed
    Score: 0.133
  18. Thyroid nodule size and prediction of cancer. J Clin Endocrinol Metab. 2013 Feb; 98(2):564-70.
    View in: PubMed
    Score: 0.131
  19. Thyroid hormone early adjustment in pregnancy (the THERAPY) trial. J Clin Endocrinol Metab. 2010 Jul; 95(7):3234-41.
    View in: PubMed
    Score: 0.109
  20. Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer. 2007 Dec 25; 111(6):508-16.
    View in: PubMed
    Score: 0.093
  21. Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors. Ann Intern Med. 2006 Nov 07; 145(9):660-4.
    View in: PubMed
    Score: 0.086
  22. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab. 2006 Sep; 91(9):3411-7.
    View in: PubMed
    Score: 0.084
  23. Thyroid nodule shape and prediction of malignancy. Thyroid. 2004 Nov; 14(11):953-8.
    View in: PubMed
    Score: 0.074
  24. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med. 2004 Jul 15; 351(3):241-9.
    View in: PubMed
    Score: 0.073
  25. Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in BRAFV600E -Driven Papillary Thyroid Cancer Patients. Clin Cancer Res. 2021 08 01; 27(15):4256-4264.
    View in: PubMed
    Score: 0.059
  26. Papillary Thyroid Carcinoma with High-Grade Features Versus Poorly Differentiated Thyroid Carcinoma: An Analysis of Clinicopathologic and Molecular Features and Outcome. Thyroid. 2021 06; 31(6):933-940.
    View in: PubMed
    Score: 0.057
  27. Histopathologic Features and Clinical Outcome of Anaplastic Thyroid Carcinoma with a Minor Anaplastic Component. Endocr Pathol. 2020 Sep; 31(3):283-290.
    View in: PubMed
    Score: 0.056
  28. Completion Thyroidectomy is Less Common Following Updated 2015 American Thyroid Association Guidelines. Ann Surg Oncol. 2021 Jan; 28(1):484-491.
    View in: PubMed
    Score: 0.055
  29. A potential diagnostic pitfall for hobnail variant of papillary thyroid carcinoma. Histopathology. 2020 Apr; 76(5):707-713.
    View in: PubMed
    Score: 0.054
  30. Prognostic Significance of Extent of Invasion in Poorly Differentiated Thyroid Carcinoma. Thyroid. 2019 09; 29(9):1255-1261.
    View in: PubMed
    Score: 0.052
  31. Quantitative Analysis of the Benefits and Risk of Thyroid Nodule Evaluation in Patients =70 Years Old. Thyroid. 2018 04; 28(4):465-471.
    View in: PubMed
    Score: 0.047
  32. Reasons Associated with Total Thyroidectomy as Initial Surgical Management of an Indeterminate Thyroid Nodule. Ann Surg Oncol. 2018 May; 25(5):1410-1417.
    View in: PubMed
    Score: 0.047
  33. Molecular Testing of Nodules with a Suspicious or Malignant Cytologic Diagnosis in the Setting of Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP). Endocr Pathol. 2018 Mar; 29(1):68-74.
    View in: PubMed
    Score: 0.047
  34. Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study. Clin Cancer Res. 2018 04 01; 24(7):1546-1553.
    View in: PubMed
    Score: 0.046
  35. The Impact of Noninvasive Follicular Variant of Papillary Thyroid Carcinoma on Rates of Malignancy for Fine-Needle Aspiration Diagnostic Categories. Thyroid. 2015 Sep; 25(9):987-92.
    View in: PubMed
    Score: 0.039
  36. How are childhood thyroid nodules discovered: opportunities for improving early detection. J Pediatr. 2014 Mar; 164(3):658-60.
    View in: PubMed
    Score: 0.035
  37. A standardized assessment of thyroid nodules in children confirms higher cancer prevalence than in adults. J Clin Endocrinol Metab. 2013 Aug; 98(8):3238-45.
    View in: PubMed
    Score: 0.034
  38. The predictive value of the fine-needle aspiration diagnosis "suspicious for a follicular neoplasm, hurthle cell type" in patients with hashimoto thyroiditis. Am J Clin Pathol. 2011 Jan; 135(1):139-45.
    View in: PubMed
    Score: 0.029
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.